glp-1 anxiety depression People with pre-existing or were less likely to have mental health worsening while taking a medication, observational Swedish data suggested. https://www.medpagetoday.com/psychiatry/generalpsychiatry/120515 Incidence of depression and anxiety
Description
Cost and Access Considerations for Long-Term GLP-1 Therapy One major barrier to long-term GLP-1 treatment has been cost

Obstructive sleep apnea is directly linked to daytime somnolence, cognitive impairment, and decreased quality of life, and has been associated with broader health conditions, including high blood pressure, heart attacks, heart failure, and diabetes

Regulatory approvals have focused on weight loss efficacy as the primary endpoint with cardiovascular benefits considered secondary outcomes
Patience is not optional here

Side effects are most common during titration

The trend is driven by cost containment
